Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
FY2025 · 10-K disclosure
FY2014 · 10-K disclosure
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 60.38 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 84.98 | Oscillator | Sell |
| Williams %R (14) | -23.50 | Oscillator | Neutral |
| MACD (12, 26, 9) | 5.64 (Hist 1.98) | Oscillator | Strong Buy |
| Average Directional Index (14) | 27.98 (+DI 29.3 / -DI 12.2) | Trend | Strong Buy |
Current price $356.68
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 1, 26 | Wayland Joseph F | officer: Executive Vice President and* | F-InKind | 144 @ $338.74 | $48.78K |
| EMA 20 | 348.48 | MA | Buy |
| SMA 20 | 343.93 | MA | Strong Buy |
| EMA 50 | 343.97 | MA | Strong Buy |
| SMA 50 | 341.72 | MA | Strong Buy |
| SMA 200 | 332.69 | MA | Strong Buy |
| Oct 22, 26 |
| Wells Fargo |
| maintain |
| Equal Weight |
| Equal Weight |
| Oct 22, 26 | Mizuho | maintain | Neutral | Neutral |
| Oct 22, 26 | Citigroup | maintain | Buy | Buy |
| Oct 21, 26 | Cantor Fitzgerald | maintain | Neutral | Neutral |
| Oct 12, 26 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Oct 12, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Oct 9, 26 | JP Morgan | maintain | Neutral | Neutral |
| Oct 7, 26 | Cantor Fitzgerald | maintain | Neutral | Neutral |
| Oct 7, 26 | Mizuho | maintain | Neutral | Neutral |
| Aug 21, 26 |
| Connors Michael P |
| director |
| S-Sale |
| 5,500 @ $345.00 |
| $1.90M |
| Jul 28, 26 | Wayland Joseph F | officer: Executive Vice President and* | S-Sale | 8,502 @ $364.54 | $3.10M |
| Jun 8, 26 | Ortega Juan Luis | officer: Executive Vice President* | M-Exempt | 3,886 @ $139.01 | $540.2K |
| Jun 8, 26 | Ortega Juan Luis | officer: Executive Vice President* | M-Exempt | 3,886 @ $139.01 | $540.2K |
| Jun 8, 26 | Ortega Juan Luis | officer: Executive Vice President* | S-Sale | 3,886 @ $322.08 | $1.25M |
| May 27, 26 | Keogh John W | officer: President &COO | S-Sale | 20,176 @ $321.45 | $6.49M |
| May 27, 26 | Keogh John W | officer: President &COO | S-Sale | 2,824 @ $321.95 | $909.2K |
Stock news · updated daily
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.
Although neither Travelers nor Chubb is cheap today, strong operating results may interest growth-minded investors.
Chubb generated $2.98 billion in core operating income during the quarter. Overseas General property and casualty premiums grew 6.7% in the quarter.
Chubb (CB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Chubb Limited ( CB ) Q3 2026 Earnings Call October 21, 2026 8:30 AM EDT Company Participants Susan Spivak Bernstein - Senior Vice President of Investor Relations Evan G. Greenberg - Chairman & CEO Peter Enns - Executive VP & CFO Conference Call Participants Meyer Shields - Keefe, Bruyette, & Woods, Inc., Research Division Matthew Heimermann - Citigroup Inc., Research Division Brian Meredith - UBS Investment Bank, Research Division Jian Huang - Morgan Stanley, Research Division Ryan Tunis - Cantor Fitzgerald & Co., Research Division Andrew Kligerman - TD Cowen, Research Division Tracy Benguigui - Wolfe Research, LLC Charles Peters - Raymond James & Associates, Inc., Research Division David Motemaden - Evercore ISI Institutional Equities, Research Division Taylor Scott - Barclays Bank PLC, Research Division Presentation Operator Thank you for standing by.
Chubb NYSE: CB reported third-quarter core operating income of $2.98 billion, or a record $7.66 per share, as underwriting, investment and life insurance income remained strong. Chairman and Chief Executive Officer Evan Greenberg said the company's diversified operations, underwriting discipline and expanding invested asset base supported the results.
CB's Q3 earnings beat estimates, fueled by record investment income and higher life insurance income, despite rising catastrophe losses pressuring underwriting.
Chubb delivered strong Q3 results, with EPS of $7.66 beating estimates and robust underwriting despite elevated catastrophe losses. CB's diversified business model enables capital allocation to higher-margin segments, supporting stable underwriting results amid premium disinflation. Investment income rose to $1.89B, with a one-time $460M gain expected from an alternatives exit; buybacks and a secure 1.2% yield continue.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 20, 2026 | 6.77 | 7.66 | Beat 13.1% | $15.14B |
| Jul 21, 2026 | 6.77 | 7.26 | Beat 7.2% | $14.71B |
| Apr 21, 2026 | 6.60 | 6.82 | Beat 3.3% | $14.01B |
| Feb 3, 2026 | 6.77 | 7.52 | Beat 11.1% | $13.13B |
| Oct 21, 2025 | 6.17 | 7.49 | Beat 21.4% | $16.14B |
| Jul 22, 2025 | 5.98 | 6.14 | Beat 2.7% | $14.90B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Oct 20, 2026 | 2026-10-20 17:24:57 | View |
| 4 | Sep 3, 2026 | 2026-09-03 16:10:03 | View |
| 4 | Aug 25, 2026 | 2026-08-25 16:10:05 | View |
| 4 | Jul 29, 2026 | 2026-07-29 16:10:03 | View |
| IRANNOTICE | Jul 28, 2026 | 2026-07-28 17:05:57 | View |
| 10-Q | Jul 28, 2026 | 2026-07-28 17:02:00 | View |
| 8-K | Jul 21, 2026 | 2026-07-21 16:10:05 | View |
| 4 | Jun 10, 2026 | 2026-06-10 16:10:03 | View |
| 8-K | Jun 10, 2026 | 2026-06-10 08:07:52 | View |
| 424B2 | Jun 5, 2026 | 2026-06-05 17:05:35 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | CB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 12.4x | 12.4x · sector 20.4x | Discount |
| Forward P/E (FY26E) | 12.4x | EPS est. 28.82 | In line |
| Price / Book | 1.9x | 1.7x | In line |
| Price / Sales | 2.2x | 2.0x | In line |
| EV / EBITDA | 13.1x | 10.7x | Elevated |
| Return on equity | 15.1% | — | Healthy |
| Gross margin | 42.7% | 27.8% | Above hist. |
| Debt / Equity | 0.26 | 0.26 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 1.02 | Distress |
Discounted cash flow model